Article Text

Download PDFPDF
Non-random transmission of mutant alleles to female offspring in BRCA carriers
  1. D G Evans1,
  2. A Shenton1,
  3. S Sharif1,
  4. E Woodward2,
  5. F Lalloo3,
  6. E R Maher4
  1. 1Academic Unit of Medical Genetics and Regional Genetics Service, St Mary’s Hospital, Manchester, UK
  2. 2Birmingham Women’s Hospital, Birmingham, UK
  3. 3Academic Unit of Medical Genetics and Regional Genetics Service, St Mary’s Hospital, Manchester, UK
  4. 4Division of Medical Genetics, Department of Paediatrics and Child Health, University of Birmingham, Birmingham, UK
  1. Correspondence to:
 D G Evans
 Medical Genetics and Regional Genetics Service, St Mary’s Hospital, Manchester, UK; gareth.evanscmmc.nhs.uk

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

We were most interested to read the report of Gronwald and colleagues suggesting that there was non-random transmission of the mutant BRCA1 gene to female offspring in a Polish cohort.1 We have undertaken a similar analysis in an English cohort but found no evidence for non-random transmission.

Gronwald et al reported that 61.5% of unaffected female offspring carried the mutant allele and this ratio did not decrease with age (as might be expected from the exclusion of affected females at advancing age). We have analysed the ratio of positive predictive tests in first degree relatives of proven mutation carriers from 284 BRCA1 and BRCA2 families from central and north western England. Like Gronwald et al1, we excluded women who were affected with cancer or whose daughter was affected as they were potential obligate carriers. We did not include branches of the family where the mutation status of the parent was unknown even if it was a mother with breast or ovarian cancer in a family with a known mutation. This excluded the possibility of including the testing of daughters of potential phenocopies. We did not reach the level of 89% uptake of predictive testing achieved with the daughters of 91 female mutation carriers in …

View Full Text

Footnotes

  • We thank Cancer Research UK (Cancer Genetics Network) for financial support.

  • Conflicting interests: none declared.